EARLYSCREEN First Trimester Screening

How does Early Screen work?

Nuchal Translucency (NT), Nasal Bone (NB) and accredited assessments are combined with hCG and PAPP-A at 11 to 13 weeks 6 days to provide patient-specific risks using the FMF algorithm for Down syndrome (DS) and Trisomy -18 and -13 (T-18/13).  Then, screening reports are called, faxed, transferred by web portal or mailed to your office.

Early Screen, combine with the 11-13 Week Scan, detects chromosomal abnormalities, about 40% of fetal heart defects, many other anomalies, and perinatal risks.

Early Screen:

  • Exceeds quad, contingent withholding sequential and integrated DS and T-18 detection rates (DR) at a lower SPR and provides T-13, twin, multiples and diabetic risk assessments.
  • Reduces DS screen positives to 4% for more accurate and safer screening than any other screening protocol (Cicero, Prenat Diagn., 2003).
  • Reassures over 95% of low-risk patients at 11-13 weeks, reduces anxiety, decreases unnecessary CVSs and amniocenteses, and saves time and cost.
  • Is strongly preferred by surveyed patients in all 11 studies.  Early testing provides patient privacy, provides the most options, and makes screening safer.
  • The Yield (PPV) for Down syndrome and Trisomies 18/13 is one affected case out of 17 CVSs or amniocenteses performed, more than 3 TIMES that of quad screening (1/75).
  • GeneCare provides fully interpreted screening risk assessments, genetic counseling, CVS, amniocentesis, and continuing education.
  • Preeclampsia – 1st trimester prenatal risk assessment

Choose Early Screen – And save time, money, and your patient's peace of mind.

  • Early, safe, accurate screening with high detection rate, low false positives and high yield.
  • Early Screen NT/hCG/PAPP-A detects 87% of DS and 80% of T-18/13 with 5% screen positive rate.
  • Early Screen with Nasal Bone detects 92% of DS and 85% of T-18/13 with 4% screen positive rate.
  • Mono- and Di-Chorionic TWIN screening: 80% DR with 7.2% SPR vs. 10.4% SPR with NT alone.
  • Early, safe, and accurate detection of ~40% of heart defects, many other anomalies and perinatal risks.
  • Strongly preferred in all patient surveys.
  • Covered by a majority of insurance providers.  *Contact us for current list.
  • Free Supplies & Transport!

Call GeneCare today for additional information or to set-up your First Trimester Screening Program.

(800) 277-4363